Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,98
KB0,58
PKN66,2566,3-0,47
Msft0,73
Nokia3,383,41750,21
IBM0,16
Mercedes-Benz Group AG71,1671,17-0,04
PFE1,91
02.05.2024 22:30:00
Indexy online
AD Index online
select
AD Index online
 

  • 02.05.2024 15:02:28
Medifast (MDFT.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
24,34 -21,33 -6,60 487
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiMedifast Inc
TickerMED
Kmenové akcie:Ordinary Shares
RICMED
ISIN-
Prioritní akciePreference Shares Series C
Prioritní akciePreference Shares Series B
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 634
Akcie v oběhu k 06.02.2024 10 895 595
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice11445 Cronhill Dr
MěstoOWINGS MILLS
PSČ21117-2270
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 327 640 619
Fax14105818070

Business Summary: Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Medifast Inc revenues decreased 33% to $1.07B. Net income decreased 31% to $99.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research & Development Expense increase of 2% to $4.6M (expense), Other (expense) income increase from $46K to $95K (expense).
Odvětvová klasifikace
TRBC2012Special Foods & Wellbeing Products
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICMedicinals And Botanicals
SICPharmaceutical Preparations



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerDaniel Chard5810.12.202003.10.2016
Chief Financial OfficerJames Maloney5513.09.202120.07.2020
Executive Vice President, General Counsel, Corporate SecretaryJason Groves5117.06.201517.11.2011
Executive Vice President - Human ResourcesClaudia Greninger5001.10.201901.10.2019
Chief Accounting Officer, Vice President - FinanceJonathan Mackenzie5213.09.202113.09.2021
Chief Marketing Officer, Chief Business OperationsAnthony Tyree57
Vice President of Investor RelationsSteven Zenker-02.03.202302.03.2023
Chief Field OperationsNicholas Johnson43